In conclusion, we could show that in patients with type 2 diabetes mellitus, insulin therapy is related to an increased risk of being diagnosed with pneumonia and that there is no antidiabetic drug therapy in the present study which is related to a lower risk of being diagnosed with pneumonia. Here, INS is linked to susceptibility to pneumonia measurement.